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Vascular decompression for 
trigeminal neuralgia - Past, 
present and future
Sir,
Classical trigeminal neuralgia (TN) comprises a syndrome 
of chronic neuropathic facial pain, which is frequently 
excruciating and refractory to conservative treatment.[1] 
Symptomatic neurovascular conflicts at the nerve root entry 
zone are thought to be one of the essential etiological factors 
of the disease. This provided the rationale for operative 
management of therapy-resistant TN in the past.
The introduction of the operating microscope revolutionized 
the field of neurosurgery and established microvascular 
decompression (MVD) for the treatment of TN.[2] Since then, 
MVD, usually via a retrosigmoid craniotomy, has been the most 
efficacious surgical procedure for sufficient and lasting symptom 
control in patients with TN refractory to pharmacological 
therapy.[3] However, the narrow approach, the vital, complex, and 
crowded anatomy of the posterior fossa, and the deep and angled 
working space make neurosurgical treatment difficult, limits 
adequate visualization of the operative field and identification 
of neurovascular conflicts, and have frequently led to incomplete 
nerve decompression and insufficient symptom improvement. 
The advent of the endoscope gave the neurosurgeons another 
visualization tool to overcome these limitations and enabled an 
even less invasive approach than MVD.[4] Since its introduction, 
neuroendoscopy, whether in the form of endoscope-controlled 
and endoscope-assisted techniques applied as an adjunct to 
microsurgery,[4] or a fully endoscopic approach as a stand-alone 
procedure in Neurosurgery,[5] increasingly became part of 
the clinical routine in the management of TN. So far, data on 
direct comparison between the results of conventional MVD 
and of neuroendoscopic vascular decompression (NVD) of the 
trigeminal nerve, and detailed discussions of the pros and cons 
of both techniques is scarce.[6]
By optimal positioning of the patient for craniotomy and 
sufficient retraction of the cerebellum, clear advantages of 
stereoscopic MVD comprise anatomical familiarity and better 
orientation, a more comfortable sitting position and hands 
free for dissection, a proximal view of the entire operative 
field, safer passage of instruments, and fewer limitations 
of instrumentation and surgical freedom. There is also the 
benefit of potentially better and more rapid perception 
and appropriate bimanual management of intraoperative 
difficulties or complications. Important advantages of 
monoscopic NVD include reduction of the operative access, 
less cerebellar retraction and lower associated risks of 
injury, no need for repeated adjustment of the microscope, 
and insertion, removal, and exchange of instruments, as 
well as better magnification, visualization, and a panoramic 
view of the surgical field and neurovascular relationship. At 
present, the two procedures should not be seen as being 
in competition, but rather as complementary. The modern 
neurosurgeon should be familiar with both of them to ensure 
optimal patient therapy and outcome. Both MVD and NVD 
can be offered with reasonable chances of success and are 
associated with low risks. They do, however, require a certain 
learning curve and cannot replace profound anatomical 
knowledge and surgical experience and skill. Furthermore, 
a clear understanding and the appropriate use of both 
techniques within our neurosurgical armory are essential.
Currently, besides vascular decompression as the 
neuroprotective and first-line surgical approach, alternative 
second-line therapeutic options for TN with or without a 
scalpel are routinely applied. These range from neurolesional 
percutaneous procedures, such as balloon compression, glycerol 
rhizotomy,[7] and radiofrequency thermocoagulation,[8] to 
stereotactic radiosurgical methods, mainly frame-based gamma 
knife surgery,[9] but also using frameless linear accelerators,[10] 
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or cyber knife systems,[11] and neuroablative modalities via 
trigeminal dorsal root entry zone lesioning,[12] or tracto- and 
nucleotomies.[13] Finally, emerging non-neurodestructive 
neuromodulatory approaches including invasive surgical[14] 
and non-invasive transcutaneous[15] neurostimulation of 
motor cortex, and stimulation of deep brain,[16] spinal cord,[17] 
trigeminal or sphenopalatine ganglion,[18] and peripheral 
trigeminal nerve[19] or nerve field[20] complete the present 
therapeutic spectrum. These new methods, which are also 
promising both as first- and second-intention and repeat or 
salvage alternatives, need further evaluation in larger patient 
populations and in prospective randomized controlled trials.
Subsequent generations of neuro- and radiosurgeons, 
together with novel technical and clinical innovations, will 
further optimize these procedures and their combinations, 
implement completely new methods, and finally help in 
deciding whether functional neurosurgery and radiosurgery 
will replace microsurgery as the standard approach, and 
what might be the best indication and optimal technique for 
the tailored and individual management of TN in the future.
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